Department of Psychology, University of Trier, Trier, Germany.
Psychoneuroendocrinology. 2010 Aug;35(7):1034-44. doi: 10.1016/j.psyneuen.2010.01.004. Epub 2010 Feb 2.
The hypothalamic-pituitary-adrenal (HPA) axis plays a major role in the development, elicitation, and enhancement of aggressive behavior in animals. Increasing evidence suggests that this is also true for humans. Here, we report on a study of the role of basal and acute HPA axis activity in a sample of 48 healthy male and female adults. We pharmacologically enhanced cortisol levels and used the Taylor Aggression Paradigm (TAP) to induce and measure aggression (divided into three blocks). Participants either received an oral dose of 20 mg hydrocortisone (cortisol group) or a placebo (placebo group). Half of each group received high or low levels of provocation with the TAP, respectively. Before, we assessed the cortisol awakening response as a trait measure of basal HPA axis activity. Participants in the cortisol group reacted more aggressively in the third block of the TAP compared to the placebo group. Furthermore, gender interacted with treatment: only females, but not males showed enhanced aggressive behavior after cortisol administration. There was no significant difference in males between the placebo and cortisol group. Basal HPA axis activity was negatively related to aggressive behavior, but again only in females and most strongly within the placebo group. This study provides the first evidence for a causal involvement of acute HPA axis activation in aggressive behavior in humans.
下丘脑-垂体-肾上腺(HPA)轴在动物的攻击行为的发展、引发和增强中起着重要作用。越来越多的证据表明,这对人类也是如此。在这里,我们报告了一项对 48 名健康男性和女性成年人样本中基础和急性 HPA 轴活动作用的研究。我们通过药理学方法提高皮质醇水平,并使用泰勒攻击范式(TAP)来诱发和测量攻击行为(分为三个阶段)。参与者分别接受 20 毫克氢可的松(皮质醇组)或安慰剂(安慰剂组)的口服剂量。每组的一半分别接受 TAP 的高或低水平的挑衅。在这之前,我们评估了皮质醇觉醒反应作为基础 HPA 轴活动的特质衡量标准。与安慰剂组相比,皮质醇组的参与者在 TAP 的第三阶段表现出更具攻击性的反应。此外,性别与治疗相互作用:只有女性,而不是男性,在皮质醇给药后表现出增强的攻击行为。在男性中,安慰剂组和皮质醇组之间没有显著差异。基础 HPA 轴活动与攻击行为呈负相关,但同样仅在女性中,并且在安慰剂组中最强。这项研究首次提供了急性 HPA 轴激活在人类攻击行为中因果关系的证据。
Psychoneuroendocrinology. 2010-2-2
Psychoneuroendocrinology. 2004-9
Clin Endocrinol (Oxf). 2009-9-21
J Neural Transm (Vienna). 2010-3-24
Psychoneuroendocrinology. 2008-11
Front Behav Neurosci. 2018-5-2
Hum Brain Mapp. 2015-11
Psychopharmacology (Berl). 2013-2-1